Expand IBB Menu
IBB MENU

IBB ETF Profile


Family: Blackrock (iShares)
Name: iShares Biotechnology ETF
Inception Date: 5-Feb-2001
Termination Date:
Investment Objective: The iShares Biotechnology ETF seeks to track the investment results of an index composed of U.S.-listed equities in the biotechnology sector. It provides exposure to U.S. companies in the biotechnology industry.
Prospectus
Top 10 Holdings
GILEAD SCIENCES INC GILD 10.0080%
VERTEX PHARMACEUTICALS INC VRTX 8.0104%
AMGEN INC AMGN 7.0264%
REGENERON PHARMACEUTICALS INC REGN 5.3532%
IQVIA HOLDINGS INC IQV 3.6816%
ALNYLAM PHARMACEUTICALS INC ALNY 3.1710%
ARGENX SE ADR ARGX 3.1146%
METTLER TOLEDO INC MTD 2.7288%
BIONTECH SE ADR BNTX 2.4844%
ILLUMINA INC ILMN 2.3585%
Top 10 Holdings Weight: 47.9%
Number of Holdings: 218
Shares Outstanding: 48,400,000
Total Net Assets: 6,663,228,000
NAV: 137.62
Net Expense Ratio: 0.45%
Asset Class: Equities (Stocks)
Developed or Emerging: Developed Market Funds
Country: US
Region:
Strategy:
Currency:
Commodity:
Sector: Healthcare
Industry: Biotech
Dividend Type:
Tax Exempt State:
Maturity Duration:
Market Cap: Large & Mid Cap
Credit Quality:
Mortgage Bond Types:
Bond Type:
Gov't Bond Types:
Reit Type:
Leverage Direction/Factor:
Is Currency Hedged: No
US or Ex-US: Domestic